Literature DB >> 7454434

Pulmonary nonspecific defense mechanisms in cystic fibrosis. I. Phagocytic capacity of alveolar macrophages and neutrophils.

R J Cassino, D O Sordelli, C N Macri, M Kohan, M H Dillon, O H Pivetta.   

Abstract

Cystic fibrosis (CF) is the commonest cause of chronic obstruction lung disease within the first three decades of life. Because patients suffer from repeated pulmonary infections, we were interested in studying the nonspecific antibacterial mechanisms of the lungs of CF children. Fifteen CF children, 13 nontuberculous pulmonary-infected (I) children and 4 noninfected (N-I) children, who were diagnosed as having a foreign body in the air passages, were submitted to a bronchopulmonary washing. The absolute number, viability, and differential count of the cells were determined, and the phagocytic assay using the Lehrer's technique was carried out on the harvested cells. The materials obtained from CF and I patients were mucopurulent, whereas the ones from the N-I patients were not mucopurulent. The number of cells retrieved from CF and I patients was higher than that from the N-I patients. This was attributed to an increase in the absolute number of polymorphonuclear leukocytes. The phagocytic capacity of polymorphonuclear leukocytes was not different for the three groups studied, whereas that of alveolar macrophages was higher for the CF and the I patients than for the N-I ones. Inasmuch as there was no significant difference between the CF and the I patients, we conclude that the nonspecific phagocytic behavior of alveolar macrophages and pulmonary polymorphonuclear leukocytes of CF patients might be similar to the one coming from other bacterial infectious states of the lung.

Entities:  

Mesh:

Year:  1980        PMID: 7454434     DOI: 10.1203/00006450-198011000-00012

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Functional characteristics of human alveolar macrophages in lung cancer.

Authors:  N Clerici; F Leyva-Cobián; S Reboiras; P Lázaro de Mercado
Journal:  Lung       Date:  1986       Impact factor: 2.584

2.  Functional activity of peripheral mononuclear cells in cystic fibrosis: antibodies and plaque formation.

Authors:  M Götz; C C Zielinski; R Ahmad; M Eibl
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

3.  Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients.

Authors:  Neil E Alexis; Marianne S Muhlebach; David B Peden; Terry L Noah
Journal:  J Cyst Fibros       Date:  2005-12-13       Impact factor: 5.482

4.  Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.

Authors:  I Eichler; L Joris; Y P Hsu; J Van Wye; R Bram; R Moss
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

Review 5.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

6.  The effect of Pseudomonas alginate on rat alveolar macrophage phagocytosis and bacterial opsonization.

Authors:  A M Oliver; D M Weir
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.